Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:LACOSAMIDE MFCD08272557 175481-36-4,2-Acetylamino-N-benzyl-3-methoxypropanamide 175481-36-4,175481-36-4
Conbott Pharmtech Co.,Ltd. LACOSAMIDE MFCD08272557 175481-36-4,2-Acetylamino-N-benzyl-3-methoxypropanamide 175481-36-4,175481-36-4
Home > Products > Intermediates > Anti-Epileptic Intermediate > Partial-onset Seizures Treatment LACOSAMIDE 175481-36-4
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

Partial-onset Seizures Treatment LACOSAMIDE 175481-36-4

Share to:  
    Payment Type: L/C,T/T
    Min. Order: 1 Gram

Basic Info

Model No.175481-36-4

BrandConbottpharm

Additional Info

PackagingAs required

ProductivityCustomized

TransportationOcean,Air

Place of OriginChina

Supply AbilityCommercial

CertificateDocuments Support

Payment TypeL/C,T/T

Product Description

 Lacosamide(CAS175481-36-4) is also named (2R)-2-acetamido-N-benzyl-3-methoxy-propanamide which is a kind of white to off white solid. Lacosamide is a medication developed by UCB for the adjunctive treatment of partial-onset seizures, diabetic neuropathic pain and potent anticonvulsant. Molecular Formula is C13H18N2O3 and Weight is250.29.Meliting point is 141-143°C, boiling point is 536.4°C at 760 mmHg and flash point is278.2°C. Lacosamide(CAS 175481-36-4)should store in dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). We can provide high quality products with factory price.

Thera. Category: Anti-diabetic neuropathic pain 

Cas No.: 175481-36-4

SynonymLACOSAMIDE;(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide;(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;ADD 243037;Erlosamide;Harkoseride;SPM 927;(R)-2-Acetamido-N-benzyl-3-methoxypropanamide

cas175481-36-4

Molecular Formula:C13H18N2O3

Molecular Weight: 250.2936

Purity: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Lacosamide Cas No.175481-36-4 is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain  

Related intermediate:

Lacosamide 175481-36-4

OC-O-METHYL-D-SERINE (CAS 86123-95-7)

O-Methyl-D-Serine hydrochloride (CAS 86118-10-7)

Product Categories : Intermediates > Anti-Epileptic Intermediate

Product Images
  • Partial-onset Seizures Treatment LACOSAMIDE 175481-36-4
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?